Molecular mechanisms of diabetic retinopathy: potential therapeutic targets
- PMID: 25949069
- PMCID: PMC4411608
- DOI: 10.4103/0974-9233.154386
Molecular mechanisms of diabetic retinopathy: potential therapeutic targets
Abstract
Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults in United States. Research indicates an association between oxidative stress and the development of diabetes complications. However, clinical trials with general antioxidants have failed to prove effective in diabetic patients. Mounting evidence from experimental studies that continue to elucidate the damaging effects of oxidative stress and inflammation in both vascular and neural retina suggest its critical role in the pathogenesis of DR. This review will outline the current management of DR as well as present potential experimental therapeutic interventions, focusing on molecules that link oxidative stress to inflammation to provide potential therapeutic targets for treatment or prevention of DR. Understanding the biochemical changes and the molecular events under diabetic conditions could provide new effective therapeutic tools to combat the disease.
Keywords: Diabetic Retinopathy; Endoplasmic Reticulum-stress; Inflammation; Nicotinamide Adenine Dinucleotide Phosphate Oxidase; Oxidative Stress; Peroxynitrite; Therapeutics.
Conflict of interest statement
Figures

Similar articles
-
Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target.Eur J Pharmacol. 2019 Jun 15;853:381-387. doi: 10.1016/j.ejphar.2019.04.038. Epub 2019 Apr 19. Eur J Pharmacol. 2019. PMID: 31009636 Review.
-
Acrolein: A Potential Mediator of Oxidative Damage in Diabetic Retinopathy.Biomolecules. 2020 Nov 20;10(11):1579. doi: 10.3390/biom10111579. Biomolecules. 2020. PMID: 33233661 Free PMC article. Review.
-
Diabetic retinopathy: current management and experimental therapeutic targets.Pharmacotherapy. 2009 Feb;29(2):182-92. doi: 10.1592/phco.29.2.182. Pharmacotherapy. 2009. PMID: 19170588 Review.
-
Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress.Life Sci. 2018 Jan 15;193:20-33. doi: 10.1016/j.lfs.2017.12.001. Epub 2017 Dec 5. Life Sci. 2018. PMID: 29203148 Review.
-
Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.Pharmacol Res. 2019 Sep;147:104299. doi: 10.1016/j.phrs.2019.104299. Epub 2019 Jun 15. Pharmacol Res. 2019. PMID: 31207342 Free PMC article. Review.
Cited by
-
Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases.Int J Mol Sci. 2021 Dec 27;23(1):249. doi: 10.3390/ijms23010249. Int J Mol Sci. 2021. PMID: 35008675 Free PMC article. Review.
-
Modulation of p75NTR on Mesenchymal Stem Cells Increases Their Vascular Protection in Retinal Ischemia-Reperfusion Mouse Model.Int J Mol Sci. 2021 Jan 15;22(2):829. doi: 10.3390/ijms22020829. Int J Mol Sci. 2021. PMID: 33467640 Free PMC article.
-
Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential.J Diabetes Res. 2019 Aug 14;2019:5140521. doi: 10.1155/2019/5140521. eCollection 2019. J Diabetes Res. 2019. PMID: 31485452 Free PMC article. Review.
-
Mechanisms of β-adrenergic receptors agonists in mediating pro and anti-apoptotic pathways in hyperglycemic Müller cells.Mol Biol Rep. 2022 Oct;49(10):9473-9480. doi: 10.1007/s11033-022-07816-0. Epub 2022 Aug 4. Mol Biol Rep. 2022. PMID: 35925485
-
Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia.World J Diabetes. 2017 Jul 15;8(7):317-329. doi: 10.4239/wjd.v8.i7.317. World J Diabetes. 2017. PMID: 28751954 Free PMC article. Review.
References
-
- American Diabetes Association, editor. American Diabetes Association: All About Diabetes. ADA. 2014. [Last accessed on 2014 Oct 10].
-
- Ey C. Pathophysiology of diabetic retinopathy. In: LeRoith D, Breen TL, Olefsky JM, editors. Diabetes Mellitus: A Fundamental and Clinical Text. Philadelphia, PA: Lippincott Williams and Wilkins; 2004.
-
- Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48–58. - PubMed
-
- Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–88. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical